Skip to content

Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients

Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01686737
Acronym
IFaB
Enrollment
0
Registered
2012-09-18
Start date
2012-11-30
Completion date
2014-07-31
Last updated
2013-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms, Fatigue

Brief summary

Breast cancer is the most frequent cancer in women and is associated with profound restrictions of health-related quality of life and psychosocial health. More than three-quarters of women with breast cancer suffer from fatigue during cancer treatment. While exercise interventions can improve fatigue in breast cancer patients, many patients request complementary treatment approaches. Therefore, this study investigates the effects of yoga in women with breast cancer compared to aerobic exercise and usual care. It is hypothesized that yoga is more effective than usual care and equally effective as aerobic exercise.

Interventions

BEHAVIORALIyengar Yoga

* 12 weeks of Iyengar yoga * 2 weekly sessions of 60 minutes

BEHAVIORALWalking

* 12 weeks of walking * 2 weekly sessions of 60 minutes

Sponsors

Universität Duisburg-Essen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* non-metastatic invasive breast cancer * currently receiving adjuvant chemotherapy * moderate to severe chemotherapy-induced fatigue * physical and cognitive capacity to participate in yoga or walking

Exclusion criteria

* diagnosed and pharmacologically treated psychiatric disorder except depressive adaptation disorder as a reaction to cancer diagnosis * ECOG status \> 1 * prior malignancy with a disease-free survival \< 10 years except curatively treated basalioma of the skin and carcinoma in situ of the cervix * prior ductal carcinoma in situ (DCIS) ot the breast * pregnancy or breastfeeding * regular practice of yoga or walking during the past 12 months

Design outcomes

Primary

MeasureTime frameDescription
FatigueWeek 12Multidimensional Fatigue Inventory

Secondary

MeasureTime frameDescription
Health-related quality of lifeWeek 12, week 36Functional Assessment of Cancer Therapy - Breast
Depression and anxietyWeek 12, week 36Hospital Anxiety and Depression Scale
Sleep qualityWeek 12, week 36Pittsburgh Sleep Quality Index
FatigueWeek 36Multidimensional Fatigue Inventory
Salivary CortisolWeek 12, week 36Cortisol awakening response
SafetyWeek 0-36Adverse events
Perceived StressWeek 12, week 36* Perceived Stress Scale * Impact of Event Scale

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026